AGP Picks
View all

Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

Press releases published on July 21, 2026

Beacon Behavioral Partners Enters Michigan and Ohio Through Partnership with Pure Psychiatry
Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care
Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries
European Patent Office Confirms Patent Protection for SOT201, SOTIO's Clinical-Stage Immunocytokine Showing Promising Anti-Tumor Activity
PatientsLikeMe and Science 37 Partner to Unlock Trial Access for Interested, Eligible Patients
Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4:30 P.M. Eastern Time
Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
Vivex Biologics Launches VIA Linx™, a Novel Self-Assembling Synthetic Peptide Matrix, Expanding its Portfolio of Advanced Wound Care Solutions
Smile Doctors Appoints Jeff Knudson as CFO to Help Scale Next Phase of Growth
AssistRx and Medisafe Unite to Power Smarter, More Connected Patient Engagement
 VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience
Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel
Vaxart to Participate in BTIG Biotechnology Conference 2026
Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation
Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Update Bahamas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.